Key result
Rheumatoid arthritis-related inflammation accelerates atherosclerosis and increases cardiovascular risk beyond traditional factors.
Answers are grounded in this paper and cite their sources.
Similarities between the inflammatory pathways in atherosclerosis and rheumatoid arthritis (RA) are striking. Chronic systemic inflammation in RA patients leads to cardiovascular (CV) events beyond traditional cardiac risk factors. Clinicians typically focus on treating the joint manifestations of RA while neglecting to eliminate systemic inflammation, which leaves RA patients vulnerable to adverse CV events. In this review we provide an understanding of how systemic inflammation in RA accelerates atherosclerosis. This knowledge should guide therapeutic targets to minimize CV risk in RA, and may lead to insights into the inflammatory mechanisms of atherosclerosis in general.
No takes yet. Share an insight, caveat, or question.
Ku et al. (2009) conducted a review in Rheumatoid arthritis and atherosclerosis. Systemic inflammation in rheumatoid arthritis was evaluated on Atherosclerosis and cardiovascular events. Chronic systemic inflammation in rheumatoid arthritis accelerates atherosclerosis and increases cardiovascular event risk beyond traditional cardiac risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: